Home Medicine Laboratory evaluation of a flow cytometric BCR-ABL immunobead assay
Article
Licensed
Unlicensed Requires Authentication

Laboratory evaluation of a flow cytometric BCR-ABL immunobead assay

  • Zsuzsanna Hevessy , Renáta Hudák , Valéria Kiss-Sziráki , Péter Antal-Szalmás , Miklós Udvardy , László Rejtő , László Szerafin and János Kappelmayer EMAIL logo
Published/Copyright: December 17, 2011

Abstract

Background: A new flow cytometric (FC) BCR-ABL immunobead assay has been developed recently. Here we present the laboratory evaluation of the commercially available kit.

Methods: Mononuclear cells were isolated, lysed and processed according to the instructions of the manufacturer. Anti-BCR antibodies adsorbed to capture beads bind the BCR-ABL fusion proteins of the lysed cells, a phycoerythrin (PE)-conjugated anti-ABL antibody is the detector reagent and mean fluorescence intensity (MFI) signals were recorded by flow cytometry. Detection of t(9;22)(q34;q11) translocation was carried out with a quantitative PCR assay.

Results: MFI results of 20 normal peripheral blood samples were 88±8 (mean±SD), CV 9%. K562 cells were used as positive control. Within-batch imprecision was excellent (3.7% in the normal and 10% in the pathological range). Cut-off was chosen at MFI 112, where both sensitivity and specificity were 100%. Altogether 17 chronic myeloid leukemia (CML) and 16 acute leukemia samples were analyzed. All PCR positive samples (n=14) were positive with the FC method and negative results were also concordant (n=15). Frozen cell lysates can be stored up to 4 weeks without significant decrease of MFI signal.

Conclusions: The FC BCR-ABL assay is a fast, reproducible and reliable method that may be incorporated into standard flow cytometric protocols to help clinical decision-making.


Corresponding author: János Kappelmayer, Department of Laboratory Medicine, Medical and Health Science Center, University of Debrecen, 4032 Debrecen, Nagyerdei krt. 98, HungaryPhone: +3652 340006, Fax: +3652 417631

Received: 2011-9-8
Accepted: 2011-11-30
Published Online: 2011-12-17
Published in Print: 2012-04-01

©2012 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. A sensitive quantitative test strip based point-of-care albuminuria screening assay
  2. Editorials
  3. Serum biomarkers for the non-invasive diagnosis of liver fibrosis: the importance of being validated
  4. Primary blood tubes mixing: time for updated recommendations
  5. Reviews
  6. 10.1515/cclm-2011-0847
  7. The hCG assay or pregnancy test
  8. Mini Reviews
  9. The role of mean platelet volume in predicting thrombotic events
  10. The role of red blood cell distribution width in cardiovascular and thrombotic disorders
  11. Genetics and Molecular Diagnostics
  12. Comparison of different collection procedures and two methods for DNA isolation from saliva
  13. Detection of α-globin gene deletion and duplication using quantitative multiplex PCR of short fluorescent fragments
  14. High-throughput detection, genotyping and quantification of the human papillomavirus using real-time PCR
  15. General Clinical Chemistry and Laboratory Medicine
  16. Quantification of human serum insulin concentrations in clinical pharmacokinetic or bioequivalence studies: what defines the “best method”?
  17. Serum cystatin C is an early biomarker for assessment of renal function in burn patients
  18. 10.1515/cclm.2011.0849
  19. Mid-stream vs. first-voided urine collection by using automated analyzers for particle examination in healthy subjects: an Italian multicenter study
  20. Percentage of hypochromic erythrocytes as a potential marker of iron availability
  21. Laboratory evaluation of a flow cytometric BCR-ABL immunobead assay
  22. Validation and Outcome Studies
  23. Independent validation of the Enhanced Liver Fibrosis (ELF) score in the ANRS HC EP 23 Fibrostar cohort of patients with chronic hepatitis C
  24. Cancer Diagnostics
  25. Demasking of epithelial cell adhesion molecule (EpCAM) on circulating epithelial tumor cells by Tween®20 treatment in breast cancer patients
  26. Anti-thyroid peroxidase antibodies are associated with the absence of distant metastases in patients with newly diagnosed breast cancer
  27. Blood presence of circulating oncofetal fibronectin mRNA, by RT-PCR, does not represent a useful specific marker for the management and follow-up of thyroid cancer patients
  28. Serum mesothelin and megakaryocyte potentiating factor in pancreatic and biliary cancers
  29. Cardiovascular Diseases
  30. The performance of high sensitivity troponin for the diagnosis of acute myocardial infarction is underestimated
  31. The prognostic value of N-terminal pro-brain natriuretic peptide in non-ST elevation acute coronary syndromes: a meta-analysis
  32. Measurement of high-molecular-weight adiponectin is not useful in assessing coronary stenosis
  33. Letters to the Editor
  34. Serum concentration of neopterin on admission does not improve the diagnostic performance of highly-sensitive troponin I
  35. Evaluation of the interference by homogentisic acid and other organic acids on the enzymatic and Jaffé method creatinine assay
  36. A comparative analysis of the Iris iQ200 with manual microscopy as a diagnostic tool for dysmorphic erythrocytes in urine
  37. Falsely decreased ionized calcium results due to analytical interference by teriflunomide, the active metabolite of leflunomide (Arava®)
  38. Is polyethylene glycol precipitation of hyperprolactinaemic samples required when using the Beckman Coulter DxI-800 prolactin assay?
  39. Congress Abstracts
  40. ISMD2012: Ninth International Symposium on Molecular Diagnostics
  41. ArabMedLab Marrakech 2012
  42. Masthead
  43. Masthead
Downloaded on 14.2.2026 from https://www.degruyterbrill.com/document/doi/10.1515/cclm.2011.834/html
Scroll to top button